The first in vivo study targeting IL-21 in a lupus-prone MRL-Fas(lpr) mouse model—commonly used to study autoimmune diseases, such as lupus—was conducted more than 15 years ago, at a time when the production of IL-21 by Tfh cells had not yet been fully elucidated. This evidence concerns the gene IL21 and autoimmune disease.